Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.

[1]  R. Amatya,et al.  Complications and Risk Factors Associated With the Removal of Norplant Implants , 1995, Obstetrics and gynecology.

[2]  M. McCann,et al.  Progestin-only oral contraception: A comprehensive review: I. Introduction , 1994 .

[3]  M. McCann,et al.  Progestin-only oral contraception: a comprehensive review. , 1994, Contraception.

[4]  R. Rivera,et al.  A comparative evaluation of the safety and contraceptive effectiveness of 65 mg and 100 mg of 90-day norethindrone (NET) injectable microspheres: a multicenter study. , 1989, Fertility and sterility.

[5]  D. Machin,et al.  The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. , 1986, Contraception.

[6]  W. Ledger,et al.  Contraceptive efficacy of bioabsorbable pellets of norethindrone (NET) as subcutaneous implants: Phase II clinical study , 1985, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[7]  B. Saxena,et al.  Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol. , 1985, Contraception.

[8]  G. N. Gupta,et al.  Multicenter clinical trial of implanted norethindrone pellets for long-acting contraception in women. Program for Applied Research on Fertility Regulation. , 1984, Contraception.

[9]  G. N. Gupta,et al.  Subdermal norethindrone pellets -- a method for contraception? , 1979, Contraception.